HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.

AbstractOBJECTIVE:
To compare the diagnostic utility of anti-cyclic citrullinated peptide (anti-CCP) antibodies with other serological markers including rheumatoid factor (RF), anti-agalactosyl immunoglobulin G (IgG) antibody, and matrix metalloproteinase (MMP)-3 in very early rheumatoid arthritis (RA).
METHODS:
Serum concentrations of anti-CCP antibodies, RF, anti-agalactosyl IgG antibody, and MMP-3 were measured in 262 patients with RA ("total RA") including 55 patients with disease duration of less than 6 months who had not been treated before entry ("very early RA") and 116 patients with rheumatic diseases other than RA.
RESULTS:
The diagnostic sensitivity of anti-CCP antibodies was 82.4% in total RA and 67.3% in very early RA and was lower than that of RF (84.0% total RA, 83.6% very early RA) and anti-agalactosyl IgG antibody (90.5%, 90.9%), whereas specificity, positive predictive value, and diagnostic accuracy were the best among markers tested both in total RA and in very early RA. The presence of either anti-CCP antibodies or RF increased the sensitivity, but any combination of serological markers was not significantly better in diagnostic accuracy than anti-CCP antibodies alone. The rates of RF-positive subjects in anti-CCP antibody-negative patients both in total RA (43.5%) and in very early RA (61.1%) were higher than those of anti-CCP antibody-positive subjects in RF-negative patients (38.1% and 22.2%, for total RA and early RA, respectively).
CONCLUSION:
Measurement of anti-CCP antibodies, by itself, is useful for the diagnosis of RA; however, combined use of anti-CCP antibodies with RF may be more useful than either method alone for the diagnosis of very early RA.
AuthorsToshihiro Matsui, Kota Shimada, Naoko Ozawa, Hiromi Hayakawa, Futoshi Hagiwara, Hisanori Nakayama, Shoji Sugii, Yoshinori Ozawa, Shigeto Tohma
JournalThe Journal of rheumatology (J Rheumatol) Vol. 33 Issue 12 Pg. 2390-7 (Dec 2006) ISSN: 0315-162X [Print] Canada
PMID16924694 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Biomarkers
  • Immunoglobulin G
  • Peptides, Cyclic
  • agalactosyl IGG
  • cyclic citrullinated peptide
  • Rheumatoid Factor
  • Matrix Metalloproteinase 3
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Arthritis, Infectious (diagnosis)
  • Arthritis, Rheumatoid (diagnosis, immunology)
  • Autoantibodies (blood, immunology)
  • Biomarkers (blood)
  • Diagnosis, Differential
  • Early Diagnosis
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoglobulin G (blood)
  • Lupus Erythematosus, Systemic (diagnosis)
  • Male
  • Matrix Metalloproteinase 3 (blood)
  • Middle Aged
  • Peptides, Cyclic (immunology)
  • Predictive Value of Tests
  • Rheumatoid Factor (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: